| Pravardhan Rajashekar Birthi, MD | |
|
403 Lexington Cir, Grand Island, NE 68803-9728 | |
| (308) 675-3222 | |
| (308) 675-3234 |
| Full Name | Pravardhan Rajashekar Birthi |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 26 Years |
| Location | 403 Lexington Cir, Grand Island, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013161082 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 27075 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Howard County Medical Center | St paul, NE | Hospital |
| Brodstone Memorial Hosp | Superior, NE | Hospital |
| Thayer County Health Services | Hebron, NE | Hospital |
| Kearney County Health Services Hospital | Minden, NE | Hospital |
| Chi Health St. Francis | Grand island, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Grand Island Pain Relief Center Pc | 7416282868 | 6 |
| Howard County Medical Center | 5698775849 | 18 |
| Thayer County Memorial Hospital | 3577559145 | 9 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago
| Entity Name | Kearney Co Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205977873 PECOS PAC ID: 8820900780 Enrollment ID: O20040223001142 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago
| Entity Name | Brodstone Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073590626 PECOS PAC ID: 4082513015 Enrollment ID: O20040423000949 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago
| Entity Name | Thayer County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326029984 PECOS PAC ID: 3577559145 Enrollment ID: O20041008000652 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago
| Entity Name | Kearney Co Health Services |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1477585958 PECOS PAC ID: 8820900780 Enrollment ID: O20061104000252 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago
| Entity Name | Thayer County Memorial Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1326029984 PECOS PAC ID: 3577559145 Enrollment ID: O20061104000293 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago
| Entity Name | Brodstone Memorial Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1306842604 PECOS PAC ID: 4082513015 Enrollment ID: O20061215000097 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago
| Entity Name | Howard County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154626216 PECOS PAC ID: 5698775849 Enrollment ID: O20110614000460 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago
| Entity Name | Grand Island Pain Relief Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346709383 PECOS PAC ID: 7416282868 Enrollment ID: O20190708002731 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Pravardhan Rajashekar Birthi, MD 403 Lexington Cir, Grand Island, NE 68803-9728 Ph: (308) 675-3222 | Pravardhan Rajashekar Birthi, MD 403 Lexington Cir, Grand Island, NE 68803-9728 Ph: (308) 675-3222 |
News Archive
The World Health Organization (WHO) has published a Health Evidence Synthesis report this week that has gathered evidence from a wide range of studies showing arts being beneficial to health. The WHO report suggests that all forms of art including visual arts, performing arts, literature etc. could be helpful in providing support in treatment and prevention of non-communicable diseases, neurological conditions and mental illnesses.
InNexus Biotechnology Inc. a leading drug development company commercializing the next generation of antibodies based on its groundbreaking Dynamic Cross Linking (DXL) technology, today announced it has been awarded a cash grant by the U.S. government totaling $116,760 for projects related to the Company's development of DXL anti-cancer antibodies.
BioLineRx, a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reported its financial results for first quarter ended March 31, 2014.
Kaiser Health News staff writer Christopher Weaver reports: "In one of the marquee benefits of the health overhaul, the federal government will spend $5 billion to subsidize so-called high-risk pools to provide coverage for people who have trouble getting insurance because of preexisting health problems until 2014. But a new report suggests that amount may not be enough to cover their needs"
The Food and Drug Administration today announced the final rule establishing procedures for administrative detention of food under the authority of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (Bioterrorism Act). This new authority applies to food for which the agency has credible evidence or information that it presents a threat of serious adverse health consequences or death to humans or animals.
› Verified 8 days ago